<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21845515</PMID><DateCompleted><Year>2012</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2592</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical immunology</Title><ISOAbbreviation>J Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Immunosuppressive effects and mechanisms of leflunomide in dengue virus infection of human dendritic cells.</ArticleTitle><Pagination><StartPage>1065</StartPage><EndPage>1078</EndPage><MedlinePgn>1065-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10875-011-9578-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dengue virus (DENV) infection is a serious public health issue without specific treatment. We examined the potential immunomodulatory effects of leflunomide, a dihydroorotate dehydrogenase inhibitor commonly prescribed for arthritis, in DENV-stimulated monocyte-derived dendritic cells (mo-DCs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">mo-DCs were prepared from purified monocytes. Cytokine and chemokine concentrations were determined by enzyme-linked immunosorbent assay. Expression of cell surface markers or viral E protein was measured by flow cytometry. The activation of transcription factors and kinases was determined by electrophoretic mobility shift assays, Western blotting, or immunoprecipitation kinase assays. Chemotaxis assays were used to determine cell migration.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Leflunomide at therapeutic concentrations inhibited cytokine and chemokine production from DENV-infected mo-DCs. Leflunomide suppressed mo-DC maturation by downregulating the expression of both CD80 and CD86. In addition, leflunomide inhibited DENV-induced mo-DC migration and mo-DC response to chemoattractants CCL19 and CCL21. Inhibition of mo-DC migration was likely due to the suppression of CCR7 expression on mo-DCs. These events were associated with the suppression of nuclear factor kappa B and activator protein-1 signaling pathways by leflunomide.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Leflunomide preserves immunosuppressive effects, inhibiting activation of DENV-stimulated mo-DCs. Leflunomide may be helpful in the development of therapeutics for DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wan-Lin</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Miaoli County, 350, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Jun</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pei-Chih</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yi-Ting</ForeName><Initials>YT</Initials></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Seng-Ting</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Deh-Ming</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jenn-Haung</ForeName><Initials>JH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Immunol</MedlineTA><NlmUniqueID>8102137</NlmUniqueID><ISSNLinking>0271-9142</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C515370">CCR7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054415">Chemokine CCL19</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054421">Chemokine CCL21</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090722">Dihydroorotate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007555">Isoxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054400">Receptors, CCR7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018808">Transcription Factor AP-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>146588-87-6</RegistryNumber><NameOfSubstance UI="C072281">E protein TH Sman, Dengue virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.3.-</RegistryNumber><NameOfSubstance UI="D044925">Oxidoreductases Acting on CH-CH Group Donors</NameOfSubstance></Chemical><Chemical><RegistryNumber>G162GK9U4W</RegistryNumber><NameOfSubstance UI="D000077339">Leflunomide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054415" MajorTopicYN="N">Chemokine CCL19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054421" MajorTopicYN="N">Chemokine CCL21</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090722" MajorTopicYN="N">Dihydroorotate Dehydrogenase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007555" MajorTopicYN="N">Isoxazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077339" MajorTopicYN="N">Leflunomide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044925" MajorTopicYN="N">Oxidoreductases Acting on CH-CH Group Donors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054400" MajorTopicYN="N">Receptors, CCR7</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018808" MajorTopicYN="N">Transcription Factor AP-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21845515</ArticleId><ArticleId IdType="doi">10.1007/s10875-011-9578-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Immunol. 2010 May 15;184(10):5571-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20404272</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechnol Adv. 2011 Mar-Apr;29(2):239-47</Citation><ArticleIdList><ArticleId IdType="pubmed">21146601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Feb;84(4):2150-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19955306</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2010 Jan 5;396(1):30-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19897220</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 2002;41(6):421-30</Citation><ArticleIdList><ArticleId IdType="pubmed">12074690</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytokine. 2010 Dec;52(3):175-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20650649</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2003 May;27(1):1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">12727523</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2001 Oct;65(2):324-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11536240</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagn Mol Pathol. 2006 Dec;15(4):223-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17122650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2008 Nov;42(11):1679-85</Citation><ArticleIdList><ArticleId IdType="pubmed">18957628</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 1995 Nov;275(2):1043-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7473131</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2010;338:83-98</Citation><ArticleIdList><ArticleId IdType="pubmed">19802580</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Feb 1;178(3):1301-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17237376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1999 Apr;179(4):755-62</Citation><ArticleIdList><ArticleId IdType="pubmed">10068569</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jun 1;174(11):7376-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15905585</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2006 Jan;126(1):97-104</Citation><ArticleIdList><ArticleId IdType="pubmed">16417224</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 1999 Sep 27;68(6):814-25</Citation><ArticleIdList><ArticleId IdType="pubmed">10515382</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2010 Mar;85(3):450-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20060421</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2003 Jul 25;17(11):1613-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12853743</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2009 Dec;39(12):3413-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19862774</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Sep 1;177(5):3185-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16920957</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2005;7(3):R694-703</Citation><ArticleIdList><ArticleId IdType="pubmed">15899055</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2004 Aug;21(2):279-88</Citation><ArticleIdList><ArticleId IdType="pubmed">15308107</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2001 Jan 15;71(1):170-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11211189</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5777-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21436031</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2009 Jun 20;389(1-2):8-19</Citation><ArticleIdList><ArticleId IdType="pubmed">19419745</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2006 Nov;7(11):1176-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17028575</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Cell Mol Biol. 2007 Oct;37(4):379-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17541010</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2003 Aug 18;198(4):615-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12925677</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2002 Aug;76(16):8408-19</Citation><ArticleIdList><ArticleId IdType="pubmed">12134044</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2001 Feb 1;166(3):1499-506</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Nov 1;181(9):5865-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18941175</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jun 15;174(12):8163-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15944325</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2006 Mar 15;81(5):704-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16534472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2001 Apr;75(8):3501-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11264339</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2004 Apr 15;189(8):1411-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Jan 1;178(1):253-61</Citation><ArticleIdList><ArticleId IdType="pubmed">17182562</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Pulm Med. 2009 May 18;9:22</Citation><ArticleIdList><ArticleId IdType="pubmed">19450259</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Infect Dis. 2008 Aug;21(4):433-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18594298</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2008 May;20(3):251-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18388514</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Pharmacol. 2003 Aug 15;66(4):679-89</Citation><ArticleIdList><ArticleId IdType="pubmed">12906932</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2002 Oct;76(19):9877-87</Citation><ArticleIdList><ArticleId IdType="pubmed">12208965</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2004 Nov;76(5):950-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15328336</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Rev. 2009 Oct;22(4):564-81</Citation><ArticleIdList><ArticleId IdType="pubmed">19822889</ArticleId></ArticleIdList></Reference><Reference><Citation>Novartis Found Symp. 2006;277:164-71; discussion 171-6, 251-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17319161</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2004 Mar 1;103(5):1595-601</Citation><ArticleIdList><ArticleId IdType="pubmed">14592837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Mar;78(6):3046-54</Citation><ArticleIdList><ArticleId IdType="pubmed">14990723</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Invest. 2004;33(4):423-37</Citation><ArticleIdList><ArticleId IdType="pubmed">15624700</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2003 Apr 7;197(7):823-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12682107</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1995 Dec 15;270(50):29682-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8530356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2008 Jul;89(Pt 7):1605-1615</Citation><ArticleIdList><ArticleId IdType="pubmed">18559930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jan 1;174(1):395-403</Citation><ArticleIdList><ArticleId IdType="pubmed">15611263</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Aug 15;198(4):516-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18598189</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2000 Feb;68(2):702-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10639436</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2004 Dec;143(7):919-27</Citation><ArticleIdList><ArticleId IdType="pubmed">15504755</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2008 Oct;225:300-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18837790</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2008 Sep;62(3):555-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18567576</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2002 Dec;76(23):12242-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12414963</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2002 Jun;76(11):5588-97</Citation><ArticleIdList><ArticleId IdType="pubmed">11991987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>